| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |